Ricerc@Sapienza

Despite the recent reductions in the global burden of malaria, this disease remains a devastating cause of death in tropical and subtropical regions. As there is no broadly effective vaccine for malaria, prevention and treatment still rely on chemotherapy. Unfortunately, emerging resistance to the gold standard artemisinin combination therapies means that new drugs with novel modes of action are urgently needed.

Malaria is the fourth major parasitic infectious disease for humans, causing severe symptoms and life-threatening complications, which, if untreated within 24–48 h may evolve in the fatality. In the past five decades, major initiatives in the treatment and prevention of this devastating disease have been implemented in endemic areas, leading to significant progress and declining trends.